CSRC approves Taiking New Energy's IPO registration on the Science and Technology Innovation Board.
On January 22, the China Securities Regulatory Commission issued the "Reply on Approving the Initial Public Offering of Shares of Xi'an Taijin Xineng Technology Co., Ltd.".
On January 22nd, the China Securities Regulatory Commission issued the "Approval for the Initial Public Offering of Shares by Xi'an Taijin New Energy Technology Co., Ltd." It is reported that Taijin New Energy plans to list on the Shanghai Stock Exchange's Sci-Tech Innovation Board, with China Securities Co., Ltd. as the sponsoring institution, planning to raise 990 million yuan.
According to the prospectus, Taijin New Energy is mainly engaged in the research, design, production, and sales of high-end green electrolysis equipment, titanium electrodes, and metal-glass sealing products. It is a leading enterprise internationally that can provide overall solutions for high-performance electronic circuit copper foil and ultra-thin lithium copper foil production lines, as well as a major research and production base for domestic precious metal titanium electrode composite materials and electronic sealing glass materials.
Taijin New Energy can provide core equipment, key materials, and complete sets of copper foil production line solutions for high-end copper foil production, including cathode rollers for copper foil production, integrated foil machines, copper foil titanium anodes, surface treatment machines, and high-efficiency copper dissolution tanks. It can also provide high-performance titanium electrodes for industries such as green environmental protection, aluminum foil production, wet metallurgy, and electrolysis for hydrogen production, as well as glass sealing products for industries such as aerospace and military electronics, with high market recognition.
Related Articles

ZHONGZHIPHARM(03737) issues a profit warning, expecting a decrease in annual net profit of no less than 70%.

SUNHO BIO-B(02898): Jiang Xiaoling appointed as Chief Executive Officer and Chief Scientific Officer

RIMAG GROUP (02522) has issued 6.13 million H shares of bonus shares.
ZHONGZHIPHARM(03737) issues a profit warning, expecting a decrease in annual net profit of no less than 70%.

SUNHO BIO-B(02898): Jiang Xiaoling appointed as Chief Executive Officer and Chief Scientific Officer

RIMAG GROUP (02522) has issued 6.13 million H shares of bonus shares.

RECOMMEND

Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
22/01/2026

Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
22/01/2026

Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
22/01/2026


